Clinical Study
Cardiac Troponin Elevation Predicts Mortality in Patients Undergoing Orthotopic Liver Transplantation
Table 1
Baseline patient characteristics prior to transplantation.
| | |
All patients | Troponin | value | | | Negative (≤0.01) | Intermediate (0.01–0.11) | Elevated (>0.11) |
| | Age at transplantation | 58.2 | 56.1 | 61.7 | 60.5 | | | Sex | | | | | | | Male | 48 (61.5%) | 30 (71.4%) | 13 (46.4%) | 5 (62.5%) | | | Female | 30 (38.5%) | 12 (28.6%) | 15 (53.6%) | 3 (37.5%) | | | History of coronary artery disease | 12 (15.4%) | 4 (9.5%) | 6 (21.4%) | 2 (25.0%) | | | History of myocardial infarction | 2 (2.6%) | 1 (2.4%) | 1 (3.6%) | 0 (0.0%) | | | Diabetes | 25 (32.1%) | 12 (28.6%) | 11 (39.3%) | 2 (25.0%) | | | Hypertension | 28 (35.9%) | 16 (38.1%) | 9 (32.1%) | 3 (37.5%) | | | Hyperlipidemia | 13 (16.7%) | 4 (9.5%) | 9 (32.1%) | 0 (0.0%) | | | Tobacco use | 29 (37.2%) | 21 (50.0%) | 4 (14.3%) | 4 (50.0%) | | | Echocardiogram () | 75 (96.2%) | 40 (95.2%) | 27 (96.4%) | 8 (100.0%) | | | LVEF (%) | 65.1 | 63.9 | 65.8 | 68.9 | | | RV mean pressure (mm Hg) | 27.8 | 28.3 | 27.4 | 26 | | | LV diastolic size (mm) | 48.5 | 49.6 | 46.7 | 47.9 | | | LV systolic size (mm) | 30.2 | 31.3 | 28.9 | 28.1 | | | RV size | | | | | | | Normal | 72 (96.0%) | 38 (95.0%) | 27 (100.0%) | 7 (87.5%) | | | Mild enlargement | 2 (2.7%) | 1 (2.5%) | 0 (0.0%) | 1 (12.5%) | | | Moderate enlargement | 1 (1.3%) | 1 (2.5%) | 0 (0.0%) | 0 (0.0%) | | | Overall function | | | | | | | Normal function | 71 (94.7%) | 38 (95.0%) | 25 (92.6%) | 8 (100.0%) | | | Wall-motion abnormalities | 4 (5.3%) | 2 (5.0%) | 2 (7.4%) | 0 (0.0%) | | | Pretransplantation stress test | 71 (91.0%) | 36 (85.7%) | 28 (100.0%) | 7 (87.5%) | |
|
|
LVEF: left ventricular ejection fraction; RV: right ventricle; LV: left ventricle.
|
